Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alistair R W Williams

Showing results (1-10 of 44) with videos related to

Pageof 5
Sort By:
F1000Research|December 21, 2017
Uterine fibroids - what's new?Alistair R W Williams
The Journal of Family Planning and Reproductive Health Care|July 22, 2006
Does liquid-based cytology really offer any advantage?Alistair R W Williams
Gynecologic Oncology|November 10, 2006
The pattern of CD98 expression is different between uterine serous papillary carcinoma and endometrioid endometrial carcinomaHannah Monaghan, Alistair R W Williams
European Journal of Obstetrics, Gynecology, and Reproductive Biology|July 13, 2020
Effects of the levonorgestrel intrauterine system on the endometrium after long-term exposure to mifepristone: Secondary outcomes of a randomized controlled trialKiriaki Papaikonomou, Caroline Frisendahl, Alistair R W Williams, et al.
International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists|September 29, 2012
Endometrial morphology after treatment of uterine fibroids with the selective progesterone receptor modulator, ulipristal acetateAlistair R W Williams, Christine Bergeron, David H Barlow, et al.
Regulatory Toxicology and Pharmacology : RTP|March 12, 2013
A 39-week oral toxicity study of ulipristal acetate in cynomolgus monkeysOliver Pohl, Alistair R W Williams, Christine Bergeron, et al.
Current Opinion in Obstetrics & Gynecology|June 21, 2014
Selective progesterone receptor modulatorsLucy H R Whitaker, Alistair R W Williams, Hilary O D Critchley
Physiological Reviews|February 8, 2020
Physiology of the Endometrium and Regulation of MenstruationHilary O D Critchley, Jacqueline A Maybin, Gregory M Armstrong, et al.
The Journal of Clinical Endocrinology and Metabolism|December 8, 2004
Prostaglandin E2 mediates phosphorylation and down-regulation of the tuberous sclerosis-2 tumor suppressor (tuberin) in human endometrial adenocarcinoma cells via the Akt signaling pathwayKurt J Sales, Sharon Battersby, Alistair R W Williams, et al.
Endocrinology|May 5, 2007
F-prostanoid receptor regulation of fibroblast growth factor 2 signaling in endometrial adenocarcinoma cellsKurt J Sales, Sheila C Boddy, Alistair R W Williams, et al.
Pageof 5

Showing results (1-10 of 44) with videos related to

Sort By:
Pageof 5
F1000Research|December 21, 2017
Uterine fibroids - what's new?Alistair R W Williams
The Journal of Family Planning and Reproductive Health Care|July 22, 2006
Does liquid-based cytology really offer any advantage?Alistair R W Williams
Gynecologic Oncology|November 10, 2006
The pattern of CD98 expression is different between uterine serous papillary carcinoma and endometrioid endometrial carcinomaHannah Monaghan, Alistair R W Williams
European Journal of Obstetrics, Gynecology, and Reproductive Biology|July 13, 2020
Effects of the levonorgestrel intrauterine system on the endometrium after long-term exposure to mifepristone: Secondary outcomes of a randomized controlled trialKiriaki Papaikonomou, Caroline Frisendahl, Alistair R W Williams, et al.
International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists|September 29, 2012
Endometrial morphology after treatment of uterine fibroids with the selective progesterone receptor modulator, ulipristal acetateAlistair R W Williams, Christine Bergeron, David H Barlow, et al.
Regulatory Toxicology and Pharmacology : RTP|March 12, 2013
A 39-week oral toxicity study of ulipristal acetate in cynomolgus monkeysOliver Pohl, Alistair R W Williams, Christine Bergeron, et al.
Current Opinion in Obstetrics & Gynecology|June 21, 2014
Selective progesterone receptor modulatorsLucy H R Whitaker, Alistair R W Williams, Hilary O D Critchley
Physiological Reviews|February 8, 2020
Physiology of the Endometrium and Regulation of MenstruationHilary O D Critchley, Jacqueline A Maybin, Gregory M Armstrong, et al.
The Journal of Clinical Endocrinology and Metabolism|December 8, 2004
Prostaglandin E2 mediates phosphorylation and down-regulation of the tuberous sclerosis-2 tumor suppressor (tuberin) in human endometrial adenocarcinoma cells via the Akt signaling pathwayKurt J Sales, Sharon Battersby, Alistair R W Williams, et al.
Endocrinology|May 5, 2007
F-prostanoid receptor regulation of fibroblast growth factor 2 signaling in endometrial adenocarcinoma cellsKurt J Sales, Sheila C Boddy, Alistair R W Williams, et al.
Pageof 5